Intel stock extends gains after report of possible U.S. government stake
Investing.com - BofA Securities downgraded Cadre Holdings Inc. (NYSE:CDRE) from Neutral to Underperform on Wednesday, while reducing its price target to $26.00 from $38.00. The company, currently trading at a P/E ratio of 31x and an EV/EBITDA of 15.8x, appears fairly valued according to InvestingPro analysis.
The downgrade follows Cadre’s second-quarter results, which showed a 1% decline in organic growth. Despite maintaining a healthy current ratio of 3.6x and operating with moderate debt levels, BofA cited concerns about potential further pressure on organic growth in the second half of 2025.
BofA noted that management had mentioned several contract delays, contributing to the firm’s cautious outlook on Cadre’s near-term performance.
The market has already reacted negatively to Cadre’s recent earnings, with the stock trading down approximately 16% on August 6, compared to the S&P 500’s 1% gain on the same day.
BofA’s new price target of $26 is derived from a reduced EV/EBITDA multiple of 10x (down from 14x previously) on 2026 estimates, representing 0.7x relative to the S&P 500, compared to 0.9x in its previous valuation.
In other recent news, Cadre Holdings Inc. reported a strong second quarter in 2025, surpassing analysts’ expectations. The company achieved an earnings per share of $0.30, beating the forecast of $0.26, and reported revenue of $157.1 million, exceeding the anticipated $153.61 million. Despite this earnings beat, Roth/MKM has lowered its price target for Cadre Holdings to $35 from $40, although it maintained a Buy rating on the stock. The adjustment was due to mixed performance in the second quarter, with sales slightly outperforming consensus expectations but gross margins falling short. These developments have sparked discussions among investors about the company’s future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.